Skip to main content

Table 3 Dosage guide for tinzaparin

From: CATCH: a randomised clinical trial comparing long-term tinzaparin versus warfarin for treatment of acute venous thromboembolism in cancer patients

175 IU/kg body weight subcutaneously once daily

Syringe size

Body weight (kg) rounded up or down to nearest kg

Units

Volume to expel from syringe prior to injection (mL)

Injection volume (mL)

10,000 IU in 0.5 mL

<34

6,000

0.20

0.30

35–41

7,000

0.15

0.35

42–46

8,000

0.10

0.40

47–51

9,000

0.05

0.45

52–57

10,000

None

0.50

14,000 IU in 0.7 mL

58–63

11,000

0.15

0.55

64–67

12,000

0.10

0.60

68–72

13,000

0.05

0.65

73–77

14,000

None

0.70

18,000 IU in 0.9 mL

78–83

15,000

0.15

0.75

84–88

16,000

0.10

0.80

89–93

17,000

0.05

0.85

94–103

18,000

None

0.90

2 × 10,000 IU in 0.5 mL

104–124

20,000

None

2 × 0.5

1 × 10,000 IU in 0.5 mL and 1 × 14,000 IU in 0.7 mL

125–145

24,000

None

1 × 0.5 and 1 × 0.7

2 × 14,000 IU in 0.7 mL

146–165

28,000

None

2 × 0.7

1 × 14,000 IU in 0.7 mL and 1 × 18,000 IU in 0.9 mL

166–183

32,000

None

1 × 0.7 and 1 × 0.9